Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,treasuryStock,otherAssets,cash,totalCurrentLiabilities,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,netReceivables,longTermDebt,inventory,accountsPayable,changeToLiabilities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,changeToNetincome,totalCashflowsFromInvestingActivities,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,currency,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,exchange,exchangeDataDelayedBy,marketState,twoHundredDayAverageChangePercent,shortName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,market,priceHint,regularMarketChangePercent,regularMarketDayRange,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,maxAge,address1,fax,industry
t0,HCLC,-16434000.0,0,98000,,587000,3000,587000,996000,-450000,-1544000,-1544000,,-195000,,,,0,1105000,2649000,1555000,2131000,,587000,587000,18998000.0,21968000.0,-16434000.0,742000.0,5537000.0,188000.0,303000.0,-27993000.0,-7627000.0,202000.0,1854000.0,19836000.0,6141000.0,7000.0,1276000.0,4059000.0,1065000.0,2132000.0,837000.0,202000.0,-27000.0,-9000.0,80000.0,-616000.0,89000.0,-99000.0,-179000.0,80000.0,-11000.0,-284000.0,92000.0,,,-15777000.0,en-US,US,EQUITY,False,Delayed Quote,USD,0.002,0.0,0.0,0,0,finmb_277965,Other OTC,Health-Chem Corporation,USD,11336,6702,0.001,1.0,0.001 - 0.07,-0.068,-0.97142863,0.001,0.07,-0.072,-1.333,0.007495,-0.0054949997,-0.73315537,0.01457986,-0.012579859,20551,-0.0015003752,15,America/New_York,EDT,-14400000,False,False,PNK,0,PRE,-0.86282444,HEALTH-CHEM CORP,0.002,1630092972,0.0,0.002665,0.002,0.002,10619,us_market,4,0.0,0.002 - 0.002,-2.18,,,0.07,0.001,0.0075,0.0146,11.34k,6.7k,,,,0.00%,0.00%,,,,,,,,,,,0.00%,,,4:3,"Oct 15, 1980","Dec 30, 2006","Jun 29, 2007",-15.87%,-67.70%,,,5.28M,0.45,-15.00%,583k,-3.25M,-837k,-0.0720,,1.85M,0.15,8.27M,,0.20,-1.33,702k,,Value,17318,Healthcare,55,"Health-Chem Corporation, through its subsidiary, Transderm Laboratories Corporation, engages in the research, development, manufacture, and marketing of transdermal drug delivery systems in the United States. It offers transdermal nitroglycerin patches used for transdermal relief of the vascular and cardiovascular symptoms related to angina pectoris (chest pain). The company also conducts research and development activities for third parties on a contract basis. Health-Chem Corporation markets its products directly to wholesalers, distributors, retail pharmacy chains, mail order pharmacies, and group purchasing organizations, as well as indirectly to independent pharmacies, managed care organizations, hospitals, nursing homes, and pharmacy benefit management companies. The company was founded in 1970 and is based in Emigsville, Pennsylvania.",Emigsville,717-764-1191,PA,1167523200,United States,86400,101 Sinking Springs Lane,717-764-5395,Diagnostics & Research
t-1,HCLC,-17110000.0,0,118000,,-522000,3000,-522000,456000,-45000,-619000,-619000,,-197000,,,,0,1149000,1768000,1194000,97000,,-522000,-522000,18918000.0,22384000.0,-17110000.0,768000.0,5277000.0,179000.0,65000.0,-28580000.0,-7627000.0,204000.0,1953000.0,20242000.0,6140000.0,7000.0,1448000.0,3625000.0,781000.0,2142000.0,826000.0,229000.0,32000.0,-9000.0,-9000.0,10000.0,89000.0,807000.0,816000.0,80000.0,111000.0,1104000.0,1000.0,,,-16617000.0,en-US,US,EQUITY,False,Delayed Quote,USD,0.002,0.0,0.0,0,0,finmb_277965,Other OTC,Health-Chem Corporation,USD,11336,6702,0.001,1.0,0.001 - 0.07,-0.068,-0.97142863,0.001,0.07,-0.072,-1.333,0.007495,-0.0054949997,-0.73315537,0.01457986,-0.012579859,20551,-0.0015003752,15,America/New_York,EDT,-14400000,False,False,PNK,0,PRE,-0.86282444,HEALTH-CHEM CORP,0.002,1630092972,0.0,0.002665,0.002,0.002,10619,us_market,4,0.0,0.002 - 0.002,-2.18,,,0.07,0.001,0.0075,0.0146,11.34k,6.7k,,,,0.00%,0.00%,,,,,,,,,,,0.00%,,,4:3,"Oct 15, 1980","Dec 30, 2006","Jun 29, 2007",-15.87%,-67.70%,,,5.28M,0.45,-15.00%,583k,-3.25M,-837k,-0.0720,,1.85M,0.15,8.27M,,0.20,-1.33,702k,,Value,17318,Healthcare,55,"Health-Chem Corporation, through its subsidiary, Transderm Laboratories Corporation, engages in the research, development, manufacture, and marketing of transdermal drug delivery systems in the United States. It offers transdermal nitroglycerin patches used for transdermal relief of the vascular and cardiovascular symptoms related to angina pectoris (chest pain). The company also conducts research and development activities for third parties on a contract basis. Health-Chem Corporation markets its products directly to wholesalers, distributors, retail pharmacy chains, mail order pharmacies, and group purchasing organizations, as well as indirectly to independent pharmacies, managed care organizations, hospitals, nursing homes, and pharmacy benefit management companies. The company was founded in 1970 and is based in Emigsville, Pennsylvania.",Emigsville,717-764-1191,PA,1167523200,United States,86400,101 Sinking Springs Lane,717-764-5395,Diagnostics & Research
t-2,HCLC,,0,138000,,-396000,3000,-409000,432000,281000,-289000,-289000,,-194000,,,,13000,1300000,1589000,1019000,-107000,,-409000,-409000,,,,,,,,,,,,,,,,,,,,,-48000.0,-10000.0,-10000.0,-66000.0,89000.0,-712000.0,-629000.0,80000.0,-244000.0,132000.0,1000.0,-73000.0,-73000.0,,en-US,US,EQUITY,False,Delayed Quote,USD,0.002,0.0,0.0,0,0,finmb_277965,Other OTC,Health-Chem Corporation,USD,11336,6702,0.001,1.0,0.001 - 0.07,-0.068,-0.97142863,0.001,0.07,-0.072,-1.333,0.007495,-0.0054949997,-0.73315537,0.01457986,-0.012579859,20551,-0.0015003752,15,America/New_York,EDT,-14400000,False,False,PNK,0,PRE,-0.86282444,HEALTH-CHEM CORP,0.002,1630092972,0.0,0.002665,0.002,0.002,10619,us_market,4,0.0,0.002 - 0.002,-2.18,,,0.07,0.001,0.0075,0.0146,11.34k,6.7k,,,,0.00%,0.00%,,,,,,,,,,,0.00%,,,4:3,"Oct 15, 1980","Dec 30, 2006","Jun 29, 2007",-15.87%,-67.70%,,,5.28M,0.45,-15.00%,583k,-3.25M,-837k,-0.0720,,1.85M,0.15,8.27M,,0.20,-1.33,702k,,Value,17318,Healthcare,55,"Health-Chem Corporation, through its subsidiary, Transderm Laboratories Corporation, engages in the research, development, manufacture, and marketing of transdermal drug delivery systems in the United States. It offers transdermal nitroglycerin patches used for transdermal relief of the vascular and cardiovascular symptoms related to angina pectoris (chest pain). The company also conducts research and development activities for third parties on a contract basis. Health-Chem Corporation markets its products directly to wholesalers, distributors, retail pharmacy chains, mail order pharmacies, and group purchasing organizations, as well as indirectly to independent pharmacies, managed care organizations, hospitals, nursing homes, and pharmacy benefit management companies. The company was founded in 1970 and is based in Emigsville, Pennsylvania.",Emigsville,717-764-1191,PA,1167523200,United States,86400,101 Sinking Springs Lane,717-764-5395,Diagnostics & Research
t-3,HCLC,,0,120000,,-345000,3000,-345000,429000,407000,-142000,-142000,,-208000,,,,0,1619000,1761000,1212000,-203000,,-345000,-345000,,,,,,,,,,,,,,,,,,,,,-286000.0,-14000.0,-14000.0,-289000.0,89000.0,993000.0,1039000.0,78000.0,-32000.0,1913000.0,1000.0,-32000.0,-32000.0,,en-US,US,EQUITY,False,Delayed Quote,USD,0.002,0.0,0.0,0,0,finmb_277965,Other OTC,Health-Chem Corporation,USD,11336,6702,0.001,1.0,0.001 - 0.07,-0.068,-0.97142863,0.001,0.07,-0.072,-1.333,0.007495,-0.0054949997,-0.73315537,0.01457986,-0.012579859,20551,-0.0015003752,15,America/New_York,EDT,-14400000,False,False,PNK,0,PRE,-0.86282444,HEALTH-CHEM CORP,0.002,1630092972,0.0,0.002665,0.002,0.002,10619,us_market,4,0.0,0.002 - 0.002,-2.18,,,0.07,0.001,0.0075,0.0146,11.34k,6.7k,,,,0.00%,0.00%,,,,,,,,,,,0.00%,,,4:3,"Oct 15, 1980","Dec 30, 2006","Jun 29, 2007",-15.87%,-67.70%,,,5.28M,0.45,-15.00%,583k,-3.25M,-837k,-0.0720,,1.85M,0.15,8.27M,,0.20,-1.33,702k,,Value,17318,Healthcare,55,"Health-Chem Corporation, through its subsidiary, Transderm Laboratories Corporation, engages in the research, development, manufacture, and marketing of transdermal drug delivery systems in the United States. It offers transdermal nitroglycerin patches used for transdermal relief of the vascular and cardiovascular symptoms related to angina pectoris (chest pain). The company also conducts research and development activities for third parties on a contract basis. Health-Chem Corporation markets its products directly to wholesalers, distributors, retail pharmacy chains, mail order pharmacies, and group purchasing organizations, as well as indirectly to independent pharmacies, managed care organizations, hospitals, nursing homes, and pharmacy benefit management companies. The company was founded in 1970 and is based in Emigsville, Pennsylvania.",Emigsville,717-764-1191,PA,1167523200,United States,86400,101 Sinking Springs Lane,717-764-5395,Diagnostics & Research
